ClinicalTrials.Veeva

Menu

Postprandial Lipid Metabolism in Patients With Hypertriglyceridemia and Normo-lipidemic Controls: Medium Chain Fatty Acids (MCT) in Comparison to Long-chain, Saturated Fatty Acids (SFA) and Mono-unsaturated Fatty Acids (MUFA)

L

Ludwig Maximilian University of Munich

Status

Completed

Conditions

Hypertriglyceridemia

Treatments

Other: MUFA
Other: SFA
Other: MCT

Study type

Interventional

Funder types

Other

Identifiers

NCT03846908
MCT-HTG

Details and patient eligibility

About

Postprandial lipid metabolism will be evaluated in patients with hypertriglyceridemia and normo-lipidemic controls; different fats will be used (saturated fatty acids, mon-unsaturated fatty acids and medium chain fatty acids) for the oral fat challenge.

Enrollment

13 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • hypertriglyceridemia (150 mg/dl-900 mg/dl)

Exclusion criteria

  • Lipid lowering drugs or indication for Lipid lowering drugs
  • LDL-cholesterol > 190 mg/dl
  • Diabetes mellitus

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

13 participants in 3 patient groups

MCT
Experimental group
Description:
subjects start with MCT fat load
Treatment:
Other: MCT
Other: MUFA
Other: SFA
SFA
Experimental group
Description:
subjects start with SFA fat load
Treatment:
Other: MCT
Other: MUFA
Other: SFA
MUFA
Experimental group
Description:
subjects start with MUFA fat load
Treatment:
Other: MCT
Other: MUFA
Other: SFA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems